Insider · CIK 0001650691

Al-Wakeel Yasir B.

Reports to the SEC for 4 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001650691

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	MXCTMAXCYTE, INC.A Award	Director	AAward	+30.4K sh	—	—	80,998
2026-06-17	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+49.6K sh	—	—	49,579
2025-06-18	MXCTMAXCYTE, INC.A Award	Director	AAward	+29.2K sh	—	—	50,577
2025-06-18	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+50.8K sh	—	—	50,790
2024-06-11	MXCTMAXCYTE, INC.A Award	Director	AAward	+21.4K sh	—	—	21,367
2024-06-11	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+40.7K sh	—	—	40,701
2023-07-06	Kronos Bio, Inc.S Sale	Chief Financial Officer	SSale	−9,617 sh	$1.75	−$16.9K	346,102
2023-06-22	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2023-03-20	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-02-24	Kronos Bio, Inc.S Sale	Chief Financial Officer	SSale	−9,026 sh	$1.74	−$15.7K	355,719
2023-02-15	Kronos Bio, Inc.A Award	Chief Financial Officer	AAward	+139K sh	—	—	364,745
2023-02-15	Kronos Bio, Inc.Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+208K sh	—	—	208,367
2022-07-25	Kronos Bio, Inc.Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2022-07-25	Kronos Bio, Inc.A Award	Chief Financial Officer	AAward	+53.6K sh	—	—	216,841
2022-06-29	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+26.9K sh	—	—	26,900
2022-02-15	Kronos Bio, Inc.A Award	Chief Financial Officer	AAward	+53.6K sh	—	—	163,241
2022-02-15	Kronos Bio, Inc.Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2021-08-09	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-12-09	Kronos Bio, Inc.Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+109K sh	—	—	108,633
2020-12-09	Kronos Bio, Inc.A Award	Chief Financial Officer	AAward	+72.4K sh	—	—	109,641
2020-10-14	Kronos Bio, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,250 sh	$19.00	+$99.8K	37,219
2020-05-06	Neon Therapeutics, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−197K sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−100K sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−61K sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−193K sh	—	—	0
2020-02-29	Neon Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−4,891 sh	$1.50	−$7,336.5	196,965
2020-02-25	Neon Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−5,385 sh	$1.51	−$8,131.35	201,856
2020-01-12	Neon Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+65K sh	—	—	207,241
2019-11-25	Neon Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+75K sh	—	—	142,241
2019-02-27	Neon Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+50K sh	—	—	67,241
2019-02-27	Neon Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2018-07-17	Neon Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−17.2K sh	—	—	192,759
2018-07-17	Neon Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.2K sh	$5.80	+$100K	17,241
2016-02-08	MERRIMACK PHARMACEUTICALS INCStock Option (right to buy)A Award	CFO and Head of Corp Dev	AAward	+105K sh	—	—	105,000
2015-08-11	MERRIMACK PHARMACEUTICALS INCStock Option (right to buy)A Award	CFO and Head of Corp Dev	AAward	+300K sh	—	—	300,000

Recent filings

Accepted (ET)
Jun 224
Al-Wakeel Yasir B.0000905148-26-003049
SEC(opens sec.gov)
Jun 234
Al-Wakeel Yasir B.0000905148-25-002228
SEC(opens sec.gov)
Jun 134
Al-Wakeel Yasir B.0001415889-24-016710
SEC(opens sec.gov)
Jul 74
Al-Wakeel Yasir B.0001209191-23-041786
SEC(opens sec.gov)
Jun 234
Al-Wakeel Yasir B.0001209191-23-039486
SEC(opens sec.gov)
Mar 214
Al-Wakeel Yasir B.0001209191-23-020291
SEC(opens sec.gov)
Feb 244
Al-Wakeel Yasir B.0001209191-23-013015
SEC(opens sec.gov)
Feb 174
Al-Wakeel Yasir B.0001209191-23-010574
SEC(opens sec.gov)
Jul 274
Al-Wakeel Yasir B.0001209191-22-043290
SEC(opens sec.gov)
Jul 84
Al-Wakeel Yasir B.0001209191-22-041614
SEC(opens sec.gov)
Feb 174
Al-Wakeel Yasir B.0001209191-22-010899
SEC(opens sec.gov)
Aug 114
Al-Wakeel Yasir B.0001209191-21-050925
SEC(opens sec.gov)
Dec 114
Al-Wakeel Yasir B.0001209191-20-062941
SEC(opens sec.gov)

Companies

Address

C/O MAXCYTE, INC. 9713 KEY WEST AVENUE, SUITE 400

ROCKVILLE, MD, 20850